William Rieflin Net Worth & Insider Trades
William Rieflin - Director, Rapt Therapeutics, Inc
What is William Rieflin's Net Worth?
The current estimated net worth of Rapt Therapeutics, Inc's Director, William Rieflin, is estimated to be about $13.91M . William Rieflin owns about 94,722 units of Rapt Therapeutics, Inc common stock. In the last 3 years at Rapt Therapeutics, Inc, William Rieflin has sold an estimated value of $0 worth.
What is William Rieflin's Past Insider Trading?
William Rieflin's largest purchase order was 10,000 units , worth over $162.2K on November 20, 2020. In total, William Rieflin has made about 7 transactions over 3 years of their time at Rapt Therapeutics, Inc. William Rieflin usually trades in November, with the busiest year in 2022, 2019 and 2020.
William Rieflin
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is William Rieflin's' Mailing Address?
- Mailing address is Ngm Biopharmaceuticals, Inc. 333 Oyster Point Blvd. South San Francisco CA 94080 CA
What are Rapt Therapeutics, Inc's Past Insider Trades?
Rapt Therapeutics, Inc's most recent insider trade came on January 26, 2023 by William Ho who sold 5,000 units worth $150K . In the last 4 years, insiders at Rapt Therapeutics, Inc have sold an estimated value of $81.68M and bought an estimated value of $49.69M worth of shares. Insider trading is most common in May, with the busiest year in 2021. The most active traders at the company are William Ho, Chief Medical Officer, Dirk G Brockstedt, Chief Scientific Officer, and Wendye Robbins, Director .
RAPT Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||